Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

Condition:   Central Nervous System Lymphoma Interventions:   Drug: Selinexor;   Drug: Rituximab;   Drug: Methotrexate Sponsors:   Tong Chen;   Antengene Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials